Course add facility will close today at cee.kerala.gov.in, check the steps here

KEAM 2022 Course Addition Installation Ends Today

Photo: iStock

Kerala Engineering Architecture Pharmacy and Medical Exam, KEAM 2022 course add window will close today, 12th May 2022. Candidates who have successfully registered for KEAM 2022 can add additional courses they wish to apply for the KEAM exam by today.
The Controller of Kerala Entrance Examinations, CEE Kerala had posted an important notice regarding the possibility of adding courses for KEAM 2022 candidates on the official website cee.kerala.gov.in. As per the notice, candidates who have applied for the KEAM 2022 exam in Engineering, Medicine or Architecture but wish to apply for another with their original choice, may do so no later than May 12, 2022 at 5:00 p.m.

The step by step process for installing KEAM 2022 course addon has been given below for applicants to refer.

KEAM 2022 – How to add courses in the KEAM app

  1. Visit the official website – cee.kerala.gov.in
  2. On the home page, click on KEAM 2022 Online Application
  3. Click on “Login” and enter your application number and password
  4. Add the course of your choice and pay the application fee.
  5. Submit the form and download it for future references.
Candidates can click on the direct link provided here to access the KEAM 2022 Application Form.
In the official noticestudents have been informed about the addition of Medicine courses and Architecture courses for KEAM 2022. those adding Architecture of course, will need to be qualified in NATA conducted by the Architecture Council,” the notice states.

Candidates applying for the Medicine courses would be required to sit for the NEET UG 2022 exam scheduled for July 17, 2022. Candidates applying for the Architecture courses would be required to sit for the NATA exam which will start on June 12, 2022 .

The last course addition date for the KEAM 2022 exam is today, May 12, 2022. No course additions will be allowed for the KEAM exam beyond 5 p.m. today.

Comments are closed.